Operating cash flow decreased 23.0%
Operating cash flow changed -23.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-$5.8M→-$7.1M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CNSY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy decreased 31.5%
Free-cash-flow proxy changed -31.5% from the comparable as-filed period.
-$5.8M→-$7.6M3 prior comparisons
Operating income decreased 488.9%
Operating income changed -488.9% from the comparable as-filed period.
-$1.5M→-$9.1M3 prior comparisons
Stock-based compensation increased 446.1%
Stock-based compensation changed +446.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$152,000→$830,0004 prior comparisons
Operating margin moved 209300 bp lower
Operating margin changed -209300 basis points from the comparable as-filed period.
-110.65%→-2203.65%2 prior comparisons
Revenue decreased 70.4%
Revenue changed -70.4% from the comparable as-filed period.
$1.4M→$411,0002 prior comparisons
Capex / revenue moved 12091 bp higher
Capex / revenue changed +12091 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.50%→121.41%2 prior comparisons
Research & development increased 242.3%
Research & development changed +242.3% from the comparable as-filed period.
$1.2M→$4.3M3 prior comparisons
Total assets increased 35.6%
Total assets changed +35.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$10.4M→$14.0M4 prior comparisons
Working capital increased 68.8%
Working capital changed +68.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.9M→$3.2M4 prior comparisons
Current assets increased 27.8%
Current assets changed +27.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$9.2M→$11.8M4 prior comparisons
Shares outstanding decreased 92.4%
Shares outstanding changed -92.4% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
99,264,526→7,589,6258 prior comparisons
SBC / revenue moved 19101 bp higher
SBC / revenue changed +19101 basis points from the comparable as-filed period.
10.94%→201.95%2 prior comparisons
R&D / revenue moved 94807 bp higher
R&D / revenue changed +94807 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
89.64%→1037.71%2 prior comparisons
Current liabilities increased 17.1%
Current liabilities changed +17.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$7.3M→$8.6M4 prior comparisons
Working capital / assets moved 450 bp higher
Working capital / assets changed +450 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
18.34%→22.84%4 prior comparisons
Free-cash-flow margin moved 143907 bp lower
Free-cash-flow margin changed -143907 basis points from the comparable as-filed period.
-417.63%→-1856.69%2 prior comparisons
Operating cash-flow margin moved 131816 bp lower
Operating cash-flow margin changed -131816 basis points from the comparable as-filed period.
-417.12%→-1735.28%2 prior comparisons
Capital expenditure changed across a low base
Capital expenditure changed +7028.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$7,000→$499,0003 prior comparisons
Cash & equivalents increased 6.0%
Cash & equivalents changed +6.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2M→$2.4M4 prior comparisons
Current ratio increased 9.1%
Current ratio changed +9.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.26→1.374 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.